Showing results (191-200 of 233) with videos related to

Sort By:
Pageof 24
British Journal of Urology|November 1, 1993
p53 expression and clinical outcome in prostate cancerD J Thomas, M Robinson, P King, et al.
The Journal of Urology|May 29, 2003
Characterization of Escherichia coli strains causing urinary tract infections in patients with transposed intestinal segmentsS J Keegan, C Graham, D E Neal, et al.
British Journal of Cancer|March 19, 2009
Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screeningN Pashayan, S W Duffy, P Pharoah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinomaG P Collett, A M Betts, M I Johnson, et al.
Lancet (London, England)|February 16, 1985
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumoursD E Neal, C Marsh, M K Bennett, et al.
British Journal of Cancer|November 1, 1987
Evaluation of epidermal growth factor receptors in bladder tumoursM S Berger, C Greenfield, W J Gullick, et al.
British Journal of Cancer|April 7, 2011
Polygenic susceptibility to prostate and breast cancer: implications for personalised screeningN Pashayan, S W Duffy, S Chowdhury, et al.
Quality in Health Care : QHC|November 4, 1995
The feasibility and cost of a large multicentre audit of process and outcome of prostatectomyM Emberton, D E Neal, N Black, et al.
British Journal of Urology|March 1, 1995
The National Prostatectomy Audit: the clinical management of patients during hospital admissionM Emberton, D E Neal, N Black, et al.
British Journal of Urology|February 1, 1997
The expression of waf-1, p53 and bcl-2 in prostatic adenocarcinomaR L Byrne, C H Horne, M C Robinson, et al.
Pageof 24